Penny E. Miller

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom et al. · Clinical Cancer Research · 2005 · 362 citations · Full text

Pharmacy, Oncology, Pharmacology +17

p185erbB2 Binds to GRP94 in Vivo

Christine Chavany, Edward G. Mimnaugh, Penny E. Miller et al. · Journal of Biological Chemistry · 1996 · 258 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +10

Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.

Penny E. Miller, C DiOrio, Mary Pat Moyer et al. · PubMed · 1994 · 113 citations

Medicine, Oncology, Pharmacology +15

Binding of Benzoquinoid Ansamycins to p100 Correlates with Their Ability to Deplete the erbB2 Gene Product p185

Penny E. Miller, Rodney C. Schnur, Elsa G. Barbacci et al. · Biochemical and Biophysical Research Communications · 1994 · 48 citations

Life Sciences, Genetics, Molecular Biology +4

The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.

Elsa G. Barbacci, Leslie R. Pustilnik, Ann Marie Rossi et al. · PubMed · 2003 · 46 citations

Medicine, Cancer Biology, Pharmacology +17